Bionano Genomics (Bionano Genomics) Change In Receivables : $-1.53 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Bionano Genomics Change In Receivables?

Bionano Genomics's change in receivables for the quarter that ended in Mar. 2024 was $1.00 Mil. It means Bionano Genomics's Accounts Receivable declined by $1.00 Mil from Dec. 2023 to Mar. 2024 .

Bionano Genomics's change in receivables for the fiscal year that ended in Dec. 2023 was $-2.30 Mil. It means Bionano Genomics's Accounts Receivable increased by $2.30 Mil from Dec. 2022 to Dec. 2023 .

Bionano Genomics's Accounts Receivable for the quarter that ended in Mar. 2024 was $8.31 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Bionano Genomics's Days Sales Outstanding for the three months ended in Mar. 2024 was 86.50.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bionano Genomics's liquidation value for the three months ended in Mar. 2024 was $-6.43 Mil.

Bionano Genomics Change In Receivables Historical Data

The historical data trend for Bionano Genomics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionano Genomics Change In Receivables Chart

Bionano Genomics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-2.37

2.09

-0.49

-2.25

-2.30

Bionano Genomics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															0.24	-0.83	-1.06	-0.65	1.00

Bionano Genomics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.53 Mil.

Bionano Genomics (NAS:BNGOW) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Bionano Genomics's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	8.313	/	8.769	*	91
=	86.50

2. In Ben Graham's calculation of liquidation value, Bionano Genomics's accounts receivable are only considered to be worth 75% of book value:

Bionano Genomics's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	52.766	-	75.224	+	0.75 * 8.313	+	0.5 * 19.587
=	-6.43

Bionano Genomics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Bionano Genomics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionano Genomics (Bionano Genomics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionano Genomics Inc (NAS:BNGOW) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

BNGO:USA BNGO:Mexico

Address

9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121

Website

https://bionano.com

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas.